Medicine and Dentistry
Patient
100%
Woman
89%
Heart Surgery
54%
Wart Virus
50%
Influenza Vaccine
42%
Disease
41%
Analysis
37%
Hospital
37%
Malignant Neoplasm
35%
Seasonal Influenza
35%
Cervical Cancer
32%
Prevalence
31%
Health
30%
Development
29%
Gene Linkage
28%
Wart Virus Vaccine
28%
Retrospective Cohort Study
28%
Influenza
27%
Immunization
27%
Healthcare Associated Infection
27%
Pregnancy Planning
27%
Cervical Intraepithelial Neoplasia
27%
Complication
27%
Age
25%
Incidence
25%
Biological Marker
24%
Colposcopy
24%
Infection
23%
Enalapril Maleate
22%
Postoperative Complication
22%
Therapeutic Procedure
21%
Intensive Care Unit
21%
Base
21%
Cohort Analysis
20%
Surgeon
20%
Anesthesiologist
20%
Infection Prevention
19%
Infection Control
19%
Observational Study
19%
Consultation
18%
Health Care Cost
18%
Epidemiologic Surveillance
18%
Genital Tract Cancer
18%
Suicidal Ideation
18%
Hyperemesis Gravidarum
18%
Cross Sectional Study
18%
Antiinfective Agent
18%
Vaccine
18%
Primary Health Care
16%
Pregnancy
16%
Nursing and Health Professions
Vaccine Efficacy
66%
Patient
58%
Screening
55%
Woman
52%
Vaccination Policy
44%
Cohort Analysis
40%
Immunization
37%
Heart Surgery
36%
Prevalence
35%
Infection
33%
Time
30%
Analysis
27%
Healthcare Associated Infection
27%
Hospital
25%
Seasonal Influenza
24%
Base
23%
Hospital Admission
23%
Primary Medical Care
22%
Health Service
20%
Influenza
19%
Confidence Interval
19%
Evaluation Study
19%
Length of Stay
19%
Prediction
19%
Cross-Sectional Study
18%
Gardasil
18%
Treatment Outcome
18%
Data Base
18%
Procedures
15%
Methicillin-Resistant Staphylococcus Aureus
15%
Adult
14%
Laboratory
14%
Complication
14%
Cost Effectiveness Analysis
13%
Consultation
12%
Control
12%
Monitoring
12%
Prevention and Control
11%
Clinical Practice
11%
Infection Prevention
11%
Infection Control
11%
Odds Ratio
11%
Influenza Vaccination
11%
Anesthesist
11%
Antiinfective Agent
11%
Electric Potential
10%
Classification
10%
Decision Support System
10%
Age Groups
10%
Postoperative Complication
10%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
52%
Vaccine
47%
Human Papillomavirus
42%
Live Attenuated Influenza Vaccine
40%
Seasonal Influenza
37%
Influenza
35%
Prevalence
31%
Cohort Study
28%
Antiinfective Agent
27%
Diseases
23%
Case-Control Study
18%
Human Papillomavirus Type 16
15%
Incidence
14%
Survival
11%
Retrospective Study
11%
Asthma
11%
Risk Assessment
10%
Healthcare Associated Infection
9%
Study Design
9%
Carbapenemase Producing Enterobacteriaceae
9%
Observational Study
9%
Infertility
9%
Chlamydiasis
9%
Animal
9%
Delirium
9%
Influenzavirus A
9%
Population Exposure
9%
Base
9%
Uterine Cervix Cancer
9%
Prognosis
9%
Rheumatic Disease
9%
Protein
9%
Genital Tract Cancer
9%
Chemotherapy
9%
Antibiotics
9%
Clostridium Difficile Infection
9%
Penis Cancer
9%
Cross-Sectional Study
9%
Biological Product
9%
Malignant Neoplasm
9%
Prospective Cohort Study
9%
Preeclampsia
9%
Vaccination Policy
9%
Wart Virus Vaccine
9%
Papillomavirus Infection
9%
Human Papillomavirus Type 18
7%
Human Papillomavirus Type 31
7%
Death
7%
Rheumatoid Arthritis
7%
Human Papillomavirus Type 45
6%
